Cargando…

Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension

BACKGROUND: Hypertensive patients are at increased risk of diastolic dysfunction. The hypothesis of this study was that addition of amlodipine would be superior to valsartan in improving diastolic dysfunction associated with hypertension. METHODS: In this randomized trial, we randomly assigned 104 c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Jin Kyung, Seo, Jeong-Sook, Park, Yong Hyun, Park, Jae-Hyeong, Lee, Seung-Ah, Lee, Sahmin, Kim, Dae-Hee, Song, Jong-Min, Kang, Duk-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Echocardiography 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316555/ https://www.ncbi.nlm.nih.gov/pubmed/32462829 http://dx.doi.org/10.4250/jcvi.2020.0005

Ejemplares similares

Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
por: Fogari, Roberto, et al.
Publicado: (2010)

Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
por: Sung, Jidong, et al.
Publicado: (2016)

Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study
por: Kim, Hae Jin, et al.
Publicado: (2017)

Simultaneous Determination of Amlodipine and Valsartan
por: Mohamed, Nashwah Gadallah
Publicado: (2011)

Efficacy of amlodipine besylate and Valsartan for the treatment of mild to moderate hypertension
por: Wang, Xiao-ou, et al.
Publicado: (2019)

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015)

Exforge(®) (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact
por: Krzesinski, Jean-Marie, et al.
Publicado: (2010)

Amlodipine and cardiovascular outcomes in hypertensive patients: meta-analysis comparing amlodipine-based versus other antihypertensive therapy
por: Lee, Seung-Ah, et al.
Publicado: (2014)

Comparison of the Ameliorating Effects of Valsartan and Amlodipine on Vascular Endothelial Dysfunction and Oxidative Stress in Elderly Patients with Type H Hypertension
por: Zhang, Lijuan, et al.
Publicado: (2022)

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010)

Reverse electromechanical modelling of diastolic dysfunction in spontaneous hypertensive rat after sacubitril/valsartan therapy
por: Sung, Yen‐Ling, et al.
Publicado: (2020)

Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients at Cardiovascular Risk
por: Yang, Yujin, et al.
Publicado: (2021)

A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension
por: Ferdinand, Keith C., et al.
Publicado: (2013)

Effectiveness and safety of valsartan/amlodipine in hypertensive patients with stroke: China Status II subanalysis
por: Zhang, Weiliang, et al.
Publicado: (2017)

Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension
por: Aabed, Wafa' J., et al.
Publicado: (2021)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Retracted: Comparison of the Ameliorating Effects of Valsartan and Amlodipine on Vascular Endothelial Dysfunction and Oxidative Stress in Elderly Patients with Type H Hypertension
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Variable Hemodynamic Responses during Diastolic Stress Echocardiography in Patients Who Have Relaxation Abnormality with Possible Elevated Filling Pressure
por: Jang, Jeong Yoon, et al.
Publicado: (2018)

Amlodipine/Valsartan (Avsar®): Efficacy in Hypertensive Patients - A Real World Observational Study (ALERT)
por: Khan, Khalid M, et al.
Publicado: (2020)

Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2018)

Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy
por: Sultan, El-Zahraa M., et al.
Publicado: (2022)

Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

Improvement of Endothelial Function by Amlodipine and Vitamin C in Essential Hypertension
por: On, Young Keun, et al.
Publicado: (2002)

Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan
por: Chan, Lung, et al.
Publicado: (2016)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorothiazide, among Palestinian hypertensive patients
por: Zaid, Abdel Naser, et al.
Publicado: (2016)

Amlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial
por: Wang, Kang-Ling, et al.
Publicado: (2020)

Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

To compare anti-albumin urea effects of valsartan alone with combination of valsartan and amlodipine in patients of chronic kidney disease
por: Ameen,, et al.
Publicado: (2016)

Amlodipine and valsartan as components of a rational and effective fixed-dose combination
por: Waeber, Bernard, et al.
Publicado: (2009)

Efficacy and Safety of Valsartan/Amlodipine Single-Pill Combination in 11,422 Chinese Patients with Hypertension: an Observational Study
por: Hu, Dayi, et al.
Publicado: (2014)

Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study
por: Hagendorff, Andreas, et al.
Publicado: (2014)

Unusual case of pleural effusion caused by amlodipine in a dog with systemic hypertension
por: Jang, Hee‐Won, et al.
Publicado: (2022)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
por: Jo, Sang-Ho, et al.
Publicado: (2018)

Risk Factors Associated with Left Ventricular Diastolic Dysfunction in Type 2 Diabetic Patients without Hypertension
por: Noh, Jung Hyun, et al.
Publicado: (2010)

Efficacies of Controlling Morning Blood Pressure and Protecting the Kidneys by Treatment With Valsartan and Nifedipine CR or Valsartan and Amlodipine (MONICA Study)
por: Tanaka, Tohru, et al.
Publicado: (2013)

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update
por: Destro, Maurizio, et al.
Publicado: (2010)

Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure
por: Doménech, Monica, et al.
Publicado: (2010)

Estimation of Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Bulk Mixture and Tablet by UV Spectrophotometry
por: Galande, Varsha R., et al.
Publicado: (2012)

Patient Adherence With Amlodipine, Lisinopril, or Valsartan Therapy in a Usual-Care Setting
por: Wogen, Jennifer, et al.
Publicado: (2003)

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension
por: Lacourcière, Y, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_92rv2kugm4v70hu9i58docrc9l